Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

NCBP2 Antikörper (AA 1-156)

NCBP2 Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7161752
  • Target Alle NCBP2 Antikörper anzeigen
    NCBP2 (Nuclear Cap Binding Protein Subunit 2 (NCBP2))
    Bindungsspezifität
    • 8
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-156
    Reaktivität
    • 33
    • 19
    • 6
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 32
    • 2
    Kaninchen
    Klonalität
    • 32
    • 2
    Polyklonal
    Konjugat
    • 22
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser NCBP2 Antikörper ist unkonjugiert
    Applikation
    • 17
    • 13
    • 13
    • 8
    • 5
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA
    Kreuzreaktivität
    Human, Maus
    Aufreinigung
    Antigen Affinity Purified
    Immunogen
    Recombinant Human Nuclear cap-binding protein subunit 2 protein (1-156AA)
    Isotyp
    IgG
    Top Product
    Discover our top product NCBP2 Primärantikörper
  • Applikationshinweise
    Recommended dilution: WB:1:500-1:1000, IHC:1:20-1:200,
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    NCBP2 (Nuclear Cap Binding Protein Subunit 2 (NCBP2))
    Andere Bezeichnung
    NCBP2 (NCBP2 Produkte)
    Synonyme
    CBP20 antikoerper, CG12357 antikoerper, Dmel\\CG12357 antikoerper, 20kDa antikoerper, 5930413E18Rik antikoerper, AA536802 antikoerper, AI843301 antikoerper, C79367 antikoerper, CHUNP6917 antikoerper, zgc:92592 antikoerper, CBC2 antikoerper, NIP1 antikoerper, ATCBP20 antikoerper, CAP-binding protein 20 antikoerper, MLN1.12 antikoerper, MLN1_12 antikoerper, Ncbp2 antikoerper, cap binding protein 20 antikoerper, nuclear cap binding protein subunit 2 antikoerper, nuclear cap binding protein subunit 2, 20kDa antikoerper, nuclear cap binding protein subunit 2 L homeolog antikoerper, nuclear cap-binding protein subunit 2 antikoerper, CAP-binding protein 20 antikoerper, Nuclear cap-binding protein subunit 2 antikoerper, Cbp20 antikoerper, Ncbp2 antikoerper, ncbp2 antikoerper, NCBP2 antikoerper, ncbp2.L antikoerper, CBP20 antikoerper, ncbp-2 antikoerper
    Hintergrund

    Background: Component of the cap-binding complex (CBC), which binds co-transcriptionally to the 5\\\' cap of pre-mRNAs and is involved in various processes such as pre-mRNA splicing, translation regulation, nonsense-mediated mRNA decay, RNA-mediated gene silencing (RNAi) by microRNAs (miRNAs) and mRNA export. The CBC complex is involved in mRNA export from the nucleus via its interaction with ALYREF/THOC4/ALY, leading to the recruitment of the mRNA export machinery to the 5\\\' end of mRNA and to mRNA export in a 5\\\' to 3\\\' direction through the nuclear pore. The CBC complex is also involved in mediating U snRNA and intronless mRNAs export from the nucleus. The CBC complex is essential for a pioneer round of mRNA translation, before steady state translation when the CBC complex is replaced by cytoplasmic cap-binding protein eIF4E. The pioneer round of mRNA translation mediated by the CBC complex plays a central role in nonsense-mediated mRNA decay (NMD), NMD only taking place in mRNAs bound to the CBC complex, but not on eIF4E-bound mRNAs. The CBC complex enhances NMD in mRNAs containing at least one exon-junction complex (EJC) via its interaction with UPF1, promoting the interaction between UPF1 and UPF2. The CBC complex is also involved in \\\'failsafe\\\' NMD, which is independent of the EJC complex, while it does not participate in Staufen-mediated mRNA decay (SMD). During cell proliferation, the CBC complex is also involved in microRNAs (miRNAs) biogenesis via its interaction with SRRT/ARS2, thereby being required for miRNA-mediated RNA interference. The CBC complex also acts as a negative regulator of PARN, thereby acting as an inhibitor of mRNA deadenylation. In the CBC complex, NCBP2/CBP20 recognizes and binds capped RNAs (m7GpppG-capped RNA) but requires NCBP1/CBP80 to stabilize the movement of its N-terminal loop and lock the CBC into a high affinity cap-binding state with the cap structure.

    Aliases: NCBP2 antibody, CBP20 antibody, PIG55 antibody, Nuclear cap-binding protein subunit 2 antibody, 20 kDa nuclear cap-binding protein antibody, Cell proliferation-inducing gene 55 protein antibody, NCBP 20 kDa subunit antibody, CBP20 antibody, NCBP-interacting protein 1 antibody, NIP1 antibody

    UniProt
    P52298
    Pathways
    Ribonucleoprotein Complex Subunit Organization, Methionine Biosynthetic Process
Sie sind hier: